Stocks and InvestingStocks and Investing
Fri, March 31, 2023
Thu, March 30, 2023
Wed, March 29, 2023

Jasper Hellweg Maintained (VRTX) at Strong Buy with Increased Target to $350 on, Mar 29th, 2023


Published on 2024-10-28 02:29:17 - WOPRAI, Jasper Hellweg
  Print publication without navigation


Jasper Hellweg of Argus Research, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $340 to $350 on, Mar 29th, 2023.

Jasper has made no other calls on VRTX in the last 4 months.



There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 6 agree with Jasper's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $300 on, Thursday, February 9th, 2023
  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Increased Target to $312 on, Wednesday, February 8th, 2023
  • Do Kim of "Piper Sandler" Maintained at Hold and Held Target at $296 on, Wednesday, February 8th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $285 on, Wednesday, February 8th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $303 on, Tuesday, February 7th, 2023
  • Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Held Target at $340 on, Monday, December 19th, 2022


These are the ratings of the 6 analyists that currently disagree with Jasper


  • William Pickering of "Bernstein" Initiated at Buy and Held Target at $344 on, Tuesday, March 21st, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $326 on, Wednesday, February 8th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $375 on, Wednesday, February 8th, 2023
  • David Risinger of "SVB Leerink" Maintained at Buy with Decreased Target to $365 on, Wednesday, February 8th, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy and Held Target at $355 on, Wednesday, February 8th, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $342 on, Wednesday, February 8th, 2023